Peapod Lane Capital LLC Takes $1.40 Million Position in Aadi Bioscience, Inc. (NASDAQ:AADI)

Peapod Lane Capital LLC purchased a new position in shares of Aadi Bioscience, Inc. (NASDAQ:AADI) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 442,942 shares of the company’s stock, valued at approximately $1,397,000. Peapod Lane Capital LLC owned about 1.80% of Aadi Bioscience at the end of the most recent reporting period.

Separately, BML Capital Management LLC acquired a new stake in Aadi Bioscience during the 3rd quarter worth $4,120,000. Institutional investors and hedge funds own 52.08% of the company’s stock.

Aadi Bioscience Trading Down 0.7 %

Shares of Aadi Bioscience stock opened at $2.68 on Thursday. The firm has a fifty day moving average of $2.90 and a two-hundred day moving average of $2.25. Aadi Bioscience, Inc. has a 52 week low of $1.21 and a 52 week high of $3.81.

About Aadi Bioscience

Aadi Bioscience, Inc, a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa.